Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Enhancer of zeste 2 polycomb repressive complex 2 subunit pseudogene 1 (EZH2P1)** is a pseudogene corresponding to the enhancer of zeste homolog 2 (EZH2) gene. It is listed in gene databases as a pseudogene and does not code for a functional protein product[1]. Therefore, it is not a functional molecular target, receptor, enzyme, or therapeutic target. **Context and clarification:** - Pseudogenes like EZH2P1 are DNA sequences similar to known genes but generally nonfunctional; they do not produce catalytically active enzymes or proteins involved in standard cellular pathways[1]. - The functional gene with related significance in cancer, histone modification, and epigenetic regulation is **Enhancer of zeste homolog 2 (EZH2)**, not EZH2P1[3][5][7]; EZH2 is a methyltransferase subunit of Polycomb Repressive Complex 2 (PRC2), highly relevant in oncology and epigenetics. - No information traces EZH2P1 to therapeutic targeting, drug interaction, or disease roles[1]. **Note:** If you intend to get information on the functional epigenetic regulator, refer instead to "Enhancer of zeste homolog 2 (EZH2)" (gene symbol: EZH2).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enhancer of zeste 2 polycomb repressive complex 2 subunit pseudogene 1 (EZH2P1).